DR JOHN HOLT'S CANCER TRIAL – HYPOGLYCAEMIA, L-GLUCOSE & UHF AN HYPOTHESIS (Number 4)

Dr John Holt (Radiotherapist, Western Australia) trialed radiowave UHF 434 MHz after insulin-induced hypoglycaemia, L-Glucose and then [L-Glucose + D-Glucose] infusions, to treat late breast cancer. He claimed very gratifying results. Given the unique form of treatment, details of the cases and an analysis of the possible biochemical effects are presented as an hypothesis here, referring to more recent scientific information. Perhaps aspects of Holt's work may have application in new ways today. Conclusion: Recent advances may support Dr John Holt's claims that UHF and glucose modulations may have value in cancer treatment.